Human trk oncogenes activated by point mutation, in-frame deletion, and duplication of the tyrosine kinase domain.

PubWeight™: 1.12‹?› | Rank: Top 10%

🔗 View Article (PMC 360953)

Published in Mol Cell Biol on August 01, 1990

Authors

F Coulier1, R Kumar, M Ernst, R Klein, D Martin-Zanca, M Barbacid

Author Affiliations

1: BRI-Basic Research Program, National Cancer Institute-Frederick Cancer Research Facility, Maryland 21701.

Articles citing this

Elevated expression of activated forms of Neu/ErbB-2 and ErbB-3 are involved in the induction of mammary tumors in transgenic mice: implications for human breast cancer. EMBO J (1999) 3.79

The trk tyrosine protein kinase mediates the mitogenic properties of nerve growth factor and neurotrophin-3. Cell (1991) 1.97

Alternative splicing generates isoforms of the met receptor tyrosine kinase which undergo differential processing. Mol Cell Biol (1991) 1.90

Genetic analysis of Ras signalling pathways in cell proliferation, migration and survival. EMBO J (2010) 1.66

A splicing variant of the RON transcript induces constitutive tyrosine kinase activity and an invasive phenotype. Mol Cell Biol (1996) 1.65

Mechanism of activation of the ret proto-oncogene by multiple endocrine neoplasia 2A mutations. Mol Cell Biol (1995) 1.44

TRKing down an old oncogene in a new era of targeted therapy. Cancer Discov (2014) 1.19

An immunoglobulin-like domain determines the specificity of neurotrophin receptors. EMBO J (1995) 1.13

TrkA immunoglobulin-like ligand binding domains inhibit spontaneous activation of the receptor. Mol Cell Biol (2000) 1.10

Identification and characterization of an activating TrkA deletion mutation in acute myeloid leukemia. Mol Cell Biol (2000) 1.10

Defective posttranslational processing activates the tyrosine kinase encoded by the MET proto-oncogene (hepatocyte growth factor receptor). Mol Cell Biol (1991) 1.06

Identification of a zinc finger protein whose subcellular distribution is regulated by serum and nerve growth factor. Proc Natl Acad Sci U S A (1999) 1.01

Mutations in the extracellular domain cause RET loss of function by a dominant negative mechanism. Mol Cell Biol (1998) 0.92

Response of cell cycle proteins to neurotrophic factor and chemokine stimulation in human neuroglia. Exp Neurol (2001) 0.89

High-affinity neurotrophin receptors and ligands promote leukemogenesis. Blood (2008) 0.84

Transforming properties and substrate specificities of the protein tyrosine kinase oncogenes ros and src and their recombinants. J Virol (1992) 0.81

New nucleotide sequence data on the EMBL File Server. Nucleic Acids Res (1991) 0.75

New nucleotide sequence data on the EMBL File Server. Nucleic Acids Res (1991) 0.75

Articles cited by this

Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science (1988) 220.77

A simple and very efficient method for generating cDNA libraries. Gene (1983) 55.36

Growth factor receptor tyrosine kinases. Annu Rev Biochem (1988) 8.67

Multiple independent activations of the neu oncogene by a point mutation altering the transmembrane domain of p185. Cell (1986) 7.06

A human oncogene formed by the fusion of truncated tropomyosin and protein tyrosine kinase sequences. Nature (1986) 5.88

Retroviruses. Science (1988) 4.22

Molecular and biochemical characterization of the human trk proto-oncogene. Mol Cell Biol (1989) 3.10

Signal transduction by allosteric receptor oligomerization. Trends Biochem Sci (1988) 2.82

Oncogenic activation of the neu-encoded receptor protein by point mutation and deletion. EMBO J (1988) 2.59

Activation of the receptor kinase domain of the trk oncogene by recombination with two different cellular sequences. EMBO J (1988) 2.19

trkB, a novel tyrosine protein kinase receptor expressed during mouse neural development. EMBO J (1989) 2.14

A point mutation in the extracellular domain of the human CSF-1 receptor (c-fms proto-oncogene product) activates its transforming potential. Cell (1988) 2.14

The viral and cellular forms of the Abelson (abl) oncogene. Adv Virus Res (1988) 2.10

Generation of protein isoform diversity by alternative splicing: mechanistic and biological implications. Annu Rev Cell Biol (1987) 1.97

High frequency of activation of tyrosine kinase oncogenes in human papillary thyroid carcinoma. Oncogene (1989) 1.94

Expression of the trk proto-oncogene is restricted to the sensory cranial and spinal ganglia of neural crest origin in mouse development. Genes Dev (1990) 1.67

Oncogenic activation of the human trk proto-oncogene by recombination with the ribosomal large subunit protein L7a. EMBO J (1990) 1.54

Frequent generation of oncogenes by in vitro recombination of TRK protooncogene sequences. Proc Natl Acad Sci U S A (1988) 1.15

Identification and biochemical characterization of p70TRK, product of the human TRK oncogene. Proc Natl Acad Sci U S A (1987) 1.14

Mechanism of activation of the human trk oncogene. Mol Cell Biol (1989) 1.03

Specific patterns of oncogene activation in transplacentally induced tumors. Proc Natl Acad Sci U S A (1990) 0.93

Avian sarcoma viruses. Virus Res (1988) 0.88

Articles by these authors

ras genes. Annu Rev Biochem (1987) 22.59

On the Oregon trail: rationing health care. BMJ (1991) 20.63

A point mutation is responsible for the acquisition of transforming properties by the T24 human bladder carcinoma oncogene. Nature (1982) 11.92

Disruption of the glucocorticoid receptor gene in the nervous system results in reduced anxiety. Nat Genet (1999) 11.79

An international classification and grading system for age-related maculopathy and age-related macular degeneration. The International ARM Epidemiological Study Group. Surv Ophthalmol (1995) 10.05

The Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol (1984) 9.28

Loss of Cdk4 expression causes insulin-deficient diabetes and Cdk4 activation results in beta-islet cell hyperplasia. Nat Genet (1999) 8.53

Role of brain insulin receptor in control of body weight and reproduction. Science (2000) 8.14

Onset of NIDDM occurs at least 4-7 yr before clinical diagnosis. Diabetes Care (1992) 7.69

The Wisconsin epidemiologic study of diabetic retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Arch Ophthalmol (1984) 7.68

Milburn's vision of a new NHS. Adopting the missionary position. BMJ (2001) 7.31

Two views on the Griffiths report. The mobilisation of consent versus the management of conflict: decoding the Griffiths report. Br Med J (Clin Res Ed) (1983) 6.16

Deep-brain stimulation of the subthalamic nucleus or the pars interna of the globus pallidus in Parkinson's disease. N Engl J Med (2001) 6.07

Methods for evaluation of retinal microvascular abnormalities associated with hypertension/sclerosis in the Atherosclerosis Risk in Communities Study. Ophthalmology (1999) 6.07

Prevalence of hearing loss in older adults in Beaver Dam, Wisconsin. The Epidemiology of Hearing Loss Study. Am J Epidemiol (1998) 6.04

Typhoid fever in children aged less than 5 years. Lancet (1999) 6.00

The Wisconsin epidemiologic study of diabetic retinopathy. IV. Diabetic macular edema. Ophthalmology (1984) 5.91

A human oncogene formed by the fusion of truncated tropomyosin and protein tyrosine kinase sequences. Nature (1986) 5.88

Explaining outputs of primary health care: population and practice factors. BMJ (1991) 5.61

Aberrant neural and cardiac development in mice lacking the ErbB4 neuregulin receptor. Nature (1995) 5.51

Prevalence of glaucoma. The Beaver Dam Eye Study. Ophthalmology (1992) 5.35

Risk factors for age-related macular degeneration: Pooled findings from three continents. Ophthalmology (2001) 5.06

Specific motifs recognized by the SH2 domains of Csk, 3BP2, fps/fes, GRB-2, HCP, SHC, Syk, and Vav. Mol Cell Biol (1994) 5.02

To cycle or not to cycle: a critical decision in cancer. Nat Rev Cancer (2001) 4.86

Roles of ephrinB ligands and EphB receptors in cardiovascular development: demarcation of arterial/venous domains, vascular morphogenesis, and sprouting angiogenesis. Genes Dev (1999) 4.75

Variations in budgets of fundholding practices. BMJ (1991) 4.71

Beta1-class integrins regulate the development of laminae and folia in the cerebral and cerebellar cortex. Neuron (2001) 4.62

The trk proto-oncogene encodes a receptor for nerve growth factor. Cell (1991) 4.54

T24 human bladder carcinoma oncogene is an activated form of the normal human homologue of BALB- and Harvey-MSV transforming genes. Nature (1982) 4.54

Enteroaggregative Escherichia coli associated with persistent diarrhea in a cohort of rural children in India. J Infect Dis (1989) 4.52

The Beaver Dam Health Outcomes Study: initial catalog of health-state quality factors. Med Decis Making (1993) 4.46

High-affinity NGF binding requires coexpression of the trk proto-oncogene and the low-affinity NGF receptor. Nature (1991) 4.44

Direct mutagenesis of Ha-ras-1 oncogenes by N-nitroso-N-methylurea during initiation of mammary carcinogenesis in rats. Nature (1985) 4.40

Induction of mammary carcinomas in rats by nitroso-methylurea involves malignant activation of H-ras-1 locus by single point mutations. Nature (1984) 4.38

Renal agenesis and the absence of enteric neurons in mice lacking GDNF. Nature (1996) 4.37

Essential role for TrkB receptors in hippocampus-mediated learning. Neuron (1999) 4.20

The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study. Neurology (1993) 4.18

gag Gene of mammalian type-C RNA tumour viruses. Nature (1976) 4.11

The 14-year incidence of visual loss in a diabetic population. Ophthalmology (1998) 4.08

Prevalence of and risk factors for dry eye syndrome. Arch Ophthalmol (2000) 3.94

Cigarette smoking and hearing loss: the epidemiology of hearing loss study. JAMA (1998) 3.86

The trk proto-oncogene product: a signal transducing receptor for nerve growth factor. Science (1991) 3.86

Identifying the content area for the 51-item National Eye Institute Visual Function Questionnaire: results from focus groups with visually impaired persons. Arch Ophthalmol (1998) 3.75

Severe sensory and sympathetic neuropathies in mice carrying a disrupted Trk/NGF receptor gene. Nature (1994) 3.73

Equity and the NHS: self-reported morbidity, access, and primary care. Br Med J (1980) 3.72

vav, a novel human oncogene derived from a locus ubiquitously expressed in hematopoietic cells. EMBO J (1989) 3.67

Assessment of cataracts from photographs in the Beaver Dam Eye Study. Ophthalmology (1990) 3.66

Visual impairment in diabetes. Ophthalmology (1984) 3.64

Warning signals from Oregon. BMJ (1992) 3.58

Essential role of p38alpha MAP kinase in placental but not embryonic cardiovascular development. Mol Cell (2000) 3.54

Characterization of rotavirus strains from newborns in New Delhi, India. J Clin Microbiol (1994) 3.50

Impact of maternal postnatal depression on cognitive development of young children. Br Med J (Clin Res Ed) (1986) 3.48

Towards a new pluralism. Health Policy (1987) 3.47

Ablation of the CDK inhibitor p57Kip2 results in increased apoptosis and delayed differentiation during mouse development. Genes Dev (1997) 3.45

Association of Rab25 and Rab11a with the apical recycling system of polarized Madin-Darby canine kidney cells. Mol Biol Cell (1999) 3.45

Myosin vb is associated with plasma membrane recycling systems. Mol Biol Cell (2001) 3.45

Enhanced gene delivery and mechanism studies with a novel series of cationic lipid formulations. J Biol Chem (1994) 3.41

Diabetic retinopathy. Diabetes Care (1998) 3.39

Tyrosine phosphorylation and tyrosine kinase activity of the trk proto-oncogene product induced by NGF. Nature (1991) 3.37

A prospective study of emotional disorders in childbearing women. Br J Psychiatry (1984) 3.33

Chlorination of taurine by human neutrophils. Evidence for hypochlorous acid generation. J Clin Invest (1982) 3.33

The prevalence of glaucoma in a population-based study of Hispanic subjects: Proyecto VER. Arch Ophthalmol (2001) 3.31

Retinal microvascular abnormalities and incident stroke: the Atherosclerosis Risk in Communities Study. Lancet (2001) 3.28

The trkB tyrosine protein kinase gene codes for a second neurogenic receptor that lacks the catalytic kinase domain. Cell (1990) 3.21

Diabetic retinopathy as detected using ophthalmoscopy, a nonmydriatic camera and a standard fundus camera. Ophthalmology (1985) 3.20

Rationing in practice: the case of in vitro fertilisation. BMJ (1993) 3.20

Review of G and P typing results from a global collection of rotavirus strains: implications for vaccine development. J Infect Dis (1996) 3.20

Nuk controls pathfinding of commissural axons in the mammalian central nervous system. Cell (1996) 3.19

Brief report: inhibition of renal phosphate transport by a tumor product in a patient with oncogenic osteomalacia. N Engl J Med (1994) 3.16

Rapid assessment of prevalence of cataract blindness at district level. Int J Epidemiol (1997) 3.14

Molecular and biochemical characterization of the human trk proto-oncogene. Mol Cell Biol (1989) 3.10

Priorities and rationing: pragmatism or principles? BMJ (1995) 3.09

Determination of the optimal aligned spacing between the Shine-Dalgarno sequence and the translation initiation codon of Escherichia coli mRNAs. Nucleic Acids Res (1994) 3.08

An alternative method of grading diabetic retinopathy. Ophthalmology (1986) 3.05

Monitoring and evaluating cataract intervention in India. Br J Ophthalmol (1996) 3.05

Oncogenes in solid human tumours. Nature (1982) 3.00

trkC, a new member of the trk family of tyrosine protein kinases, is a receptor for neurotrophin-3. Cell (1991) 2.97

Product of vav proto-oncogene defines a new class of tyrosine protein kinase substrates. Nature (1992) 2.97

Malignant activation of a K-ras oncogene in lung carcinoma but not in normal tissue of the same patient. Science (1984) 2.97

Is the risk of diabetic retinopathy greater in non-Hispanic blacks and Mexican Americans than in non-Hispanic whites with type 2 diabetes? A U.S. population study. Diabetes Care (1998) 2.97

Transcriptional repression of oestrogen receptor by metastasis-associated protein 1 corepressor. Nat Cell Biol (2001) 2.93

Biochemical and immunological characterization of polyproteins coded for by the McDonough, Gardner-Arnstein, and Snyder-Theilen strains of feline sarcoma virus. J Virol (1980) 2.92

Ten-year incidence of visual loss in a diabetic population. Ophthalmology (1994) 2.91

Neoadjuvant hormonal downsizing of localized carcinoma of the prostate: effects on the volume of normal tissue irradiation. Cancer Invest (1995) 2.90

Cause-specific mortality in a population-based study of diabetes. Am J Public Health (1991) 2.89

Low prevalence of hearing aid use among older adults with hearing loss: the Epidemiology of Hearing Loss Study. J Am Geriatr Soc (1998) 2.88

Problems in the management of attention-deficit-hyperactivity disorder. N Engl J Med (1999) 2.87

Origin and functional properties of the major gene product of the Snyder-Theilen strain of feline sarcoma virus. Proc Natl Acad Sci U S A (1980) 2.83

Tyro-3 family receptors are essential regulators of mammalian spermatogenesis. Nature (1999) 2.80

Orbitofrontal cortex dysfunction in abstinent cocaine abusers performing a decision-making task. Neuroimage (2003) 2.75

The politics of change. BMJ (1991) 2.70

Hyperoxaluric nephrolithiasis is a complication of Roux-en-Y gastric bypass surgery. Kidney Int (2007) 2.69

Prevalence of age-related lens opacities in a population. The Beaver Dam Eye Study. Ophthalmology (1992) 2.68